Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Clozel

Showing results (71-80 of 88) with videos related to

Pageof 9
Sort By:
Circulation|November 1, 1994
Role of endothelin in the maintenance of blood pressure in conscious rats with chronic heart failure. Acute effects of the endothelin receptor antagonist Ro 47-0203 (bosentan)J R Teerlink, B M Löffler, P Hess, et al.
Experimental Gerontology|February 15, 2000
Age-dependent hypertension in Mpv17-deficient mice, a transgenic model of glomerulosclerosis and inner ear diseaseM Clozel, P Hess, W Fischli, et al.
La Nouvelle Presse Medicale|May 10, 1980
[Erythema multiforme. Isolation of Mycoplasma pneumoniae from skin lesions]P Canton, M Clozel, L Neiman, et al.
The American Journal of Cardiology|April 13, 2000
Regulation of aldosterone secretion in patients with chronic congestive heart failure by endothelinsG Sütsch, O Bertel, P Rickenbacher, et al.
The American Journal of Physiology|January 1, 1995
Role of endogenous endothelin in normal hemodynamic status of anesthetized dogsJ R Teerlink, J P Carteaux, U Sprecher, et al.
Hepatology (Baltimore, Md.)|September 10, 1998
Beneficial hemodynamic effects of bosentan, a mixed ET(A) and ET(B) receptor antagonist, in portal hypertensive ratsP Sogni, R Moreau, A Gomola, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 12, 1998
Ro 61-1790, a new hydrosoluble endothelin antagonist: general pharmacology and effects on experimental cerebral vasospasmS Roux, V Breu, T Giller, et al.
Hypertension (Dallas, Tex. : 1979)|September 1, 1996
Endothelin antagonism in end-organ damage of spontaneously hypertensive rats. Comparison with angiotensin-converting enzyme inhibition and calcium antagonismH Karam, D Heudes, P Bruneval, et al.
Blood|April 15, 1993
Relationship between tissue factor expression and deposition of fibrin, platelets, and leukocytes on cultured endothelial cells under venous blood flow conditionsD Kirchhofer, K S Sakariassen, M Clozel, et al.
Cardiovascular Research|February 1, 1996
Respective role of humoral factors and blood pressure in cardiac remodeling of DOCA hypertensive ratsH Karam, D Heudes, P Hess, et al.
Pageof 9

Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
Circulation|November 1, 1994
Role of endothelin in the maintenance of blood pressure in conscious rats with chronic heart failure. Acute effects of the endothelin receptor antagonist Ro 47-0203 (bosentan)J R Teerlink, B M Löffler, P Hess, et al.
Experimental Gerontology|February 15, 2000
Age-dependent hypertension in Mpv17-deficient mice, a transgenic model of glomerulosclerosis and inner ear diseaseM Clozel, P Hess, W Fischli, et al.
La Nouvelle Presse Medicale|May 10, 1980
[Erythema multiforme. Isolation of Mycoplasma pneumoniae from skin lesions]P Canton, M Clozel, L Neiman, et al.
The American Journal of Cardiology|April 13, 2000
Regulation of aldosterone secretion in patients with chronic congestive heart failure by endothelinsG Sütsch, O Bertel, P Rickenbacher, et al.
The American Journal of Physiology|January 1, 1995
Role of endogenous endothelin in normal hemodynamic status of anesthetized dogsJ R Teerlink, J P Carteaux, U Sprecher, et al.
Hepatology (Baltimore, Md.)|September 10, 1998
Beneficial hemodynamic effects of bosentan, a mixed ET(A) and ET(B) receptor antagonist, in portal hypertensive ratsP Sogni, R Moreau, A Gomola, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 12, 1998
Ro 61-1790, a new hydrosoluble endothelin antagonist: general pharmacology and effects on experimental cerebral vasospasmS Roux, V Breu, T Giller, et al.
Hypertension (Dallas, Tex. : 1979)|September 1, 1996
Endothelin antagonism in end-organ damage of spontaneously hypertensive rats. Comparison with angiotensin-converting enzyme inhibition and calcium antagonismH Karam, D Heudes, P Bruneval, et al.
Blood|April 15, 1993
Relationship between tissue factor expression and deposition of fibrin, platelets, and leukocytes on cultured endothelial cells under venous blood flow conditionsD Kirchhofer, K S Sakariassen, M Clozel, et al.
Cardiovascular Research|February 1, 1996
Respective role of humoral factors and blood pressure in cardiac remodeling of DOCA hypertensive ratsH Karam, D Heudes, P Hess, et al.
Pageof 9